Taiwan's ScinoPharm Builds New Manufacturing Plant in Jiangsu Province; Says Mainland's Stronger IP Environment, Growing Market Make It More Attractive
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - Looking to leverage mainland China's production capacity and, potentially, its rapidly growing pharmaceutical market, Taiwan-based active pharmaceutical ingredients manufacturer ScinoPharm is building a new manufacturing facility in Jiangsu Province